LivaNova (LIVN) FCF Margin Growth (3y) (2019 - 2026)
LivaNova (LIVN) FCF Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 127.82 Bn | 124.35 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 73.38 Bn | 72.84 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.44 Bn | 32.50 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.80 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 60.00 |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 1,700.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,700.00 |
| Mar 31, 2026 | -365.00 |
| Dec 31, 2025 | 1,042.00 |
| Sep 30, 2025 | 566.00 |
| Jun 30, 2025 | 1,999.00 |
| Mar 31, 2025 | -442.00 |
| Dec 31, 2024 | 1,163.00 |
| Sep 30, 2024 | 216.00 |
| Jun 30, 2024 | 252.00 |
| Mar 31, 2024 | -333.00 |
| Dec 31, 2023 | 195.00 |
| Sep 30, 2023 | 406.00 |
| Jun 30, 2023 | 755.00 |
| Mar 31, 2023 | 5,226.00 |
| Dec 31, 2022 | 523.00 |
| Sep 30, 2022 | 4,246.00 |
| Jun 30, 2022 | 238.00 |
| Mar 31, 2022 | 1,008.00 |
| Dec 31, 2021 | 689.00 |
| Sep 30, 2021 | -625.00 |